Autoimmune Disorder Drug Delivery Devices Market to Witness Rapid...

Autoimmune Disorder Drug Delivery Devices Market to Witness Rapid Expansion at 16.89% CAGR by 2027

Postado 2024-09-16 08:56:29

1KB

This comprehensive Autoimmune Disorder Drug Delivery Devices Market report by “MarkNtel Advisors: Leading Market research Company” offers valuable insights into the current and future market landscape, providing clarity on potential challenges and strategies for optimal brand positioning. It features detailed market segmentation, in-depth analysis of key market players, emerging trends in consumer behavior and supply chain dynamics, and opportunities in new geographical markets. With the insights from this report, you can manage your marketing strategies for goods and services more effectively.

“According to recent market analysis report, the Global Autoimmune Disorder Drug Delivery Devices Market is expected to grow at a CAGR of 16.89% during the forecast period of 2022 to 2027.”

“In case you missed it, we are currently revising our reports. Click on the below to get the most latest research data with forecasts for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”

Download Sample PDF Copy of this Report: - https://www.marknteladvisors.com/query/request-sample/global-autoimmune-disorder-drug-delivery-devices-market.html

Key Trend in the Autoimmune Disorder Drug Delivery Devices Market

Proliferating Trend Towards Self-Administration & Better Homecare to Support the Market Growth - A significant increase in the adoption of self-injectable devices for the treatment of autoimmunity disorders such as diabetes etc., combined with the rapid surge in hospital-acquired infections, high medical costs, and longer wait hauls, have accelerated the shift towards the use of autoimmune disorder drug delivery devices in households globally. Moreover, various companies such as Becton, Dickinson, and Insulet Corporation have launched self-injectable devices to bring economic benefits to both patients & healthcare systems. For instance, pressure-assisted auto-injectors by Antares Pharma are a form of parenteral drug delivery to address acute & chronic medical needs such as rheumatoid arthritis, allergic reactions, psoriasis, and other therapies.

Market Segment Highlights:

By Product Type

Prefilled Syringes
Auto-injectors
Infusion pumps
Nebulizers
Nasal sprays
Others (Eyedropper, Transdermal patches, etc.)

Among them, Prefilled Syringes hold a prominent share in the market, owing to the rising demand for convenient & safe-filled syringes over conventional glass vials for parental drug packing. Moreover, a growing number of biosimilars & biologics in the market are supporting the growth of prefilled syringes across the world. In addition, technological advancements, rising adoption of self-injecting parenteral devices, and supportive government regulations are propelling the growth of prefilled syringes for autoimmune disorders

By Indication

Psoriasis
Rheumatoid Arthritis
Multiple Sclerosis
Inflammatory Bowel Diseases
Systemic Lupus Erythematosus
Diabetes Mellitus
Others (Guillain Barre Syndrome, Grave’s Disease, etc.)

By Manufacturing Type

In-House Manufacturing
Outsourced Manufacturing

By End User

Hospitals
Diagnostic centres
Ambulatory surgery centres
Others (Clinics, Home care settings, etc.)

Autoimmune Disorder Drug Delivery Devices Market Regional Outlook:

North America
South America
Europe
The Middle East & Africa
Asia-Pacific.

Explore the Full Report with Charts, Table of Contents, and List of Figures - https://www.marknteladvisors.com/research-library/global-autoimmune-disorder-drug-delivery-devices-market.html

Autoimmune Disorder Drug Delivery Devices Market Competition Analysis:

Some of the top Autoimmune Disorder Drug Delivery Devices companies operating in the market are Amgen Inc., AbbVie Inc., Bayer AG, Biogen Inc., Eli Lilly and Company, Bristol-Myers Squibb Company, F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., The Merck Group, Novartis International AG, Sanofi S.A., Teva Pharmaceutical Industries Ltd., UCB Pharma SA..

Who We Are:

Our team entails professional analysts and researchers who intelligently utilize research techniques to procure detail-driven, unbiased, and reliable data encompassing the industry. We aim to nurture a result-oriented team to offer strategically-moving insights to our clients.

Our fact-based reports allow the user to design their motives, funds, and strategies, with a higher focus on mitigating confusion and bringing forward a clear insight into the industry. It further allows the clients to identify the lucrative opportunities awaiting.

Insights offered by MarkNtel Advisors comprise in-depth information on regional & country-based trends emerging in the industry. The team studies & compiles the prospects, ensuring consistency in reports.

Our services are beyond offering research reports to the clients and further expand into addressing queries while incorporating with them for advice, development, & execution of strategies for exception growth.